.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Cipla
Express Scripts
McKesson
Boehringer Ingelheim
Federal Trade Commission
Julphar
Healthtrust
Moodys

Generated: February 18, 2018

DrugPatentWatch Database Preview

Patents Expiring in February 2029

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Mobius TherapMITOSOLmitomycinFOR SOLUTION;TOPICAL022572-001Feb 7, 2012RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
ApilLO MINASTRIN FEethinyl estradiol; norethindrone acetateTABLET, CHEWABLE, TABLET;ORAL204654-001Jul 24, 2013DISCNYesNo➤ Try a Free Trial➤ Try a Free TrialPREVENTION OF PREGNANCY
ApilLO LOESTRIN FEethinyl estradiol; norethindrone acetateTABLET;ORAL022501-001Oct 21, 2010ABRXYesYes➤ Try a Free Trial➤ Try a Free TrialLO LOESTRIN FE IS INDICATED FOR THE PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOF OF CONTRACEPTION
OrexigenCONTRAVEbupropion hydrochloride; naltrexone hydrochlorideTABLET, EXTENDED RELEASE;ORAL200063-001Sep 10, 2014RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Takeda Pharms UsaACTOPLUS METmetformin hydrochloride; pioglitazone hydrochlorideTABLET;ORAL021842-002Aug 29, 2005ABRXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Takeda Pharms UsaACTOPLUS METmetformin hydrochloride; pioglitazone hydrochlorideTABLET;ORAL021842-001Aug 29, 2005ABRXYesNo➤ Try a Free Trial➤ Try a Free TrialY
Astrazeneca AbBYDUREON PENexenatide syntheticFOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200-002Feb 28, 2014RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Pf Prism CvTYGACILtigecyclinePOWDER;IV (INFUSION)021821-001Jun 15, 2005APRXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Glaxo Grp EnglandINCRUSE ELLIPTA umeclidinium bromidePOWDER;INHALATION205382-001Apr 30, 2014RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
GlaxosmithklineARNUITY ELLIPTAfluticasone furoatePOWDER;INHALATION205625-002Aug 20, 2014RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Citi
Dow
Queensland Health
Mallinckrodt
Novartis
Teva
Harvard Business School
Colorcon
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot